NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer

Authors :: Saverio Cinieri
M Groc
L. Garcia Estevez
G. Villanova
H Hervieu
Roberto Hegg
M. Ruiz Borrego
Matti Aapro
Serafin Morales
R. De Freitas Junior
Elżbieta Starosławska
E. Szombara
Source :: European Journal of Cancer. 92:S98
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Advanced breast
HER2 negative
Weekly paclitaxel
Cancer
Estrogen receptor
Phases of clinical research
medicine.disease
Vinorelbine
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools